Newsletter Subject

Dementia-Drinking Link; Rebranding 'Mommy Brain'; Wild Dreams and Parkinson's

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Feb 11, 2023 12:18 PM

Email Preheader Text

Weekly Review Saturday, February 11, 2023 WORDOSIS CME SPOTLIGHT ADVERTISEMENT CME SPOTLIGHT CME SPO

[MEDPAGE TODAY]( Weekly Review Saturday, February 11, 2023 [Dementia-Drinking Link; Rebranding 'Mommy Brain'; Wild Dreams and Parkinson's]( [Is Orthrus the Next Top-Dog COVID Variant?]( [Can High-Dose Vitamin D Prevent Diabetes?]( WORDOSIS [Play Today's Wordosis: Our Medical Word Game]( CME SPOTLIGHT [Adapting Gastrointestinal Cancer Care to the Latest Evidence in Biomarker-Informed Treatment Decision Making]( [Dead Patient Sues America's Frontline Doctors Over HCQ; Pair Accused of Bilking Doc]( [Ketamine Clinics Are Jumping Ahead of the Evidence]( ADVERTISEMENT [U.S. Exercise Levels; Lifestyle and Memory Decline; Cooling Kidney Donors]( CME SPOTLIGHT [Individualizing Treatment to Advance Integration of New Evidence and Quality Care in von Willebrand Disease]( [AI Tool Forecasts Lung Cancer Risk From a Single CT Scan]( [Levothyroxine Recall; Klotho & Osteoporosis Protection; Marriage for a Lower HbA1c?]( [Here's How to End the U.S. Health Disadvantage]( CME SPOTLIGHT [Expert Strategies for Integrating CAR T-cell Therapy in Relapsed/Refractory Multiple Myeloma Care]( [Here's Why Experts Are Concerned About Bird Flu]( [Lower Excess Mortality Seen for Physicians vs General Public During COVID Pandemic]( [Healthy Lifestyle Before Infection Linked to Lower Long COVID Risk]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Cardiac Monitoring Continues to Flag Unsuspected Afib in Broader Population]( [Blood Test Predicts Which People With Amyloid Are Likely to Decline Cognitively]( [ChatGPT Tackles Cardiology; Cocoa Powder's CVD Claims Permitted; Lyme Carditis Death]( CME SPOTLIGHT [Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes]( [Are AI Chatbots in Healthcare Ethical?]( [Hospitals at a Breaking Point: Lack of Staff and Resources Leave EDs in Chaos]( [AUD Diagnoses After COVID Infection Higher at Certain Points in the Pandemic]( CME SPOTLIGHT [Transforming Treatment and Management Strategies for Patients With AML]( [Doctors Not Immune to Political Biases When it Comes to COVID]( [Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades']( [New Guidance Targets Infection Hazards in Fingernails, Sinks, Excessive Hand-Washing]( CME SPOTLIGHT [Transforming HR+/HER2- Breast Cancer Care: Real-world Patient and Provider Perspectives]( [Do Weight-Loss Startups Have a Future?]( [COVID Vaccines Added to 2023 Child, Adult Immunization Schedules]( [Winning the Impossible: The Power of a Nurses' Strike]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( ['The Evil Hand Is Mother Nature': What We Heard This Week]( [Single-Dose Antibiotic Reduced Maternal Sepsis in Vaginal Delivery]( [Thrombectomy Effective for Large Ischemic Strokes]( [Higher Pay for Healthcare Staff? Ease Burnout by Using Your PTO]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-02-11&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.